SCHEMBL2493738

SCHEMBL2493738

CCOC(=O)c1sc(Cl)nc1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
DHODH Q02127 8/20 0.55
ALDH1A1 P00352 4/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 1/20 0.50
RORB Q92753 3/20 0.49
KDM4E B2RXH2 1/20 0.49
HSP90AA1 P07900 1/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
TRPM8 Q7Z2W7 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1970502 0.89 MAPT (0.67) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL11165291 0.87 ALDH1A1 (0.69) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL2491226 0.86 MEN1 (0.62) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL11278694 0.86 MAPT (0.64) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL11281010 0.85 ALDH1A1 (0.55) MEN1KMT2ADHODHALDH1A1HPGD
SCHEMBL2492109 0.85 TRPM8 (0.65) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL11292190 0.82 ALDH1A1 (0.58) MEN1KMT2AALDH1A1RORBKDM4E
SCHEMBL3893108 0.82 ALDH1A1 (0.71) MEN1KMT2ADHODHALDH1A1HPGD
SCHEMBL11278911 0.82 MAPT (0.54) MAPTMEN1KMT2ADHODHALDH1A1
SCHEMBL6288115 0.80 FNTA (0.54) MEN1KMT2ADHODHALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379543-A2 THIAZOLYL-BENZIMIDAZOLES F. Hoffmann-La Roche AG (CH) 2011-10-26 EP disclosed
US-8044213-B2 Thiazolyl-benzimidazoles HOFFMANN-LA ROCHE INC. (US) 2011-10-25 US disclosed
WO-2010121675-A2 THIAZOLYL-BENZIMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO disclosed
US-20100160308-A1 Thiazolyl-Benzimidazoles CAI JIANPING 2010-06-24 US disclosed
US-4336389-A 2-Substituted-4-aryl-5-thiazolecarboxylic acids and their derivatives as safening agents MONSANTO COMPANY (US) 1982-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160308-A1 Thiazolyl-Benzimidazoles CYP3A7, CYP2C19, CYP3A5 MAPT 1573/4885MEN1 557/4885KMT2A 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.